A Double-blind, Randomized, Single Dose, Placebo Controlled, Three Part Study to Evaluate the Safety and Tolerability, Efficacy and Dose Response of SAF312 in Postoperative Dental Pain Patients.
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs SAF 312 (Primary) ; Ibuprofen
- Indications Dental pain; Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 05 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 08 Oct 2009 New trial record